Information only — no products are sold on this website.
NJ100 · Pen · Cellular energy research
A coenzyme central to cellular energy metabolism. Widely studied in ageing biology; injectable and infusion presentations are not established approved therapies.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in all living cells and central to redox metabolism. Oral precursors are sold as supplements in many markets; injectable and IV presentations sit in a different regulatory category.
NAD+ participates in redox reactions and serves as a substrate for sirtuins and PARP enzymes, pathways studied in ageing and metabolic research.
Human research largely concerns oral precursors and reports biomarker changes; clinical-outcome evidence remains emerging. Evidence for injectable or IV NAD+ delivering claimed benefits is limited.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.